ParamergeParamerge

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

National Cancer Institute (NIH)

Planning grants to gather the information needed to design a cancer prevention or control trial: characterising the study population, testing recruitment approaches, assessing intervention feasibility and resolving operational risks before a full trial.

Indicative award
up to $225k per year (per year)Page publishes $225,000 direct costs per year, capped at $450,000 total over a 3-year period without a pilot/feasibility trial, or $600,000 total with one. No floor is published.
Timing
Several times a yearSeveral times a year · Feb, Jun, OctNo specific published date recorded. This funder publishes a cycle rather than a date, and this database does not invent one.Due dates fall on a February 25 / June 25 / October 25 cycle running from February 25, 2025 through October 25, 2027. Expiration date October 26, 2027.
Who can apply
Early-career faculty, Mid-career & senior, Any faculty rank
Eligibility
Higher education institutions, nonprofit organisations, for-profits, government agencies, tribal organisations and foreign organisations may apply. Any individual with the requisite skills and institutional resources may serve as PD/PI.
SSWR clusters
Topics
clinical trial planning · feasibility · recruitment · cancer control
Apply at
https://grants.nih.gov/grants/guide/pa-files/PAR-25-104.html
This entry
Curated by the working group. Written 2026-08-07. The funder link has not yet been machine-checked.

Amounts and dates on this page are indicative and are maintained by people rather than scraped. Funders change ceilings, windows and eligibility without notice; confirm all details at the source above before applying.

← Back to the database